These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5338900)

  • 1. Corticosteroids in pulmonary tuberculosis. II. Importance of background factors.
    Johnson JR; Turk TL; MacDonald FM
    Am Rev Respir Dis; 1967 Jul; 96(1):43-61. PubMed ID: 5338900
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticosteroids in pulmonary tuberculosis. 3. Indications.
    Johnson JR; Turk TL; MacDonald FM
    Am Rev Respir Dis; 1967 Jul; 96(1):62-73. PubMed ID: 5338901
    [No Abstract]   [Full Text] [Related]  

  • 3. Prednisone as an adjunct in the chemotherapy of lymph node-bronchial tuberculosis in childhood: a double-blind study. II. Further term observation.
    Nemir RL; Cardona J; Vaziri F; Toledo R
    Am Rev Respir Dis; 1967 Mar; 95(3):402-10. PubMed ID: 5335164
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspects of the tuberculosis situation in Denmark, especially chemoresistance.
    Kok-Jensen A; Torning K
    Scand J Respir Dis Suppl; 1969; 69():17-20. PubMed ID: 4906371
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of single and divided daily dosages of isoniazid and PAS in the treatment of pulmonary tuberculosis. XV. A report of the Veterans Administration-Armed Forces Cooperative. Study on the chemotherapy of tuberculosis.
    Reisner D
    Am Rev Respir Dis; 1966 Dec; 94(6):849-57. PubMed ID: 4958797
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative studies with isoniazid alone, isoniazid with thiacetazone and isoniazid with para-aminosalicylic acid in ambulatory treatment of pulmonary tuberculosis.
    Patel RB; Patel TL; Mehta HC
    J Indian Med Assoc; 1967 May; 48(10):471-8. PubMed ID: 4167188
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems related to ambulatory treatment with isoniazid and aminosalicylic acid].
    Waisbich E; de Barros RF
    Hospital (Rio J); 1967 Nov; 72(5):1547-50. PubMed ID: 5307829
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-resistant pulmonary tuberculosis in Norway. Preliminary report.
    Bjartveit K
    Scand J Respir Dis Suppl; 1969; 69():21-2. PubMed ID: 5264216
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifampin therapy of pulmonary tuberculosis in patients not treated previously with antituberculous drugs.
    Eidus L; Jessamine AG; Helbaque DM; Narasimhan V
    Int J Clin Pharmacol; 1974 Jan; 9(1):81-6. PubMed ID: 4593132
    [No Abstract]   [Full Text] [Related]  

  • 13. [Controlled intermittent treatment of pulmonary tuberculosis using streptomycin, isoniazid and PAS once, twice or 3 times a week].
    el-Fassi el-Fahri M; Burzoni FJ; Durante C; Ceicu A
    Bull Int Union Tuberc; 1973 Dec; 48 Suppl():158-65. PubMed ID: 4611550
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of efficiency of large and small doses of isoniazid in combined treatment in pulmonary tuberculosis].
    Mysakowska H; Grodzki S; Przemyska B; Szarewicz W; Srednicka D
    Pol Tyg Lek; 1965 Apr; 20(16):562-4. PubMed ID: 5834844
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inactivation of PAS and isoniazid in children with tuberculosis].
    Shenderova RI; Terterian EA
    Probl Tuberk; 1973; 51(5):67-71. PubMed ID: 4757049
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proceedings: Significance and limits of controlled clinical research (in pulmonary tuberculosis)].
    Bignall JR
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):103-6. PubMed ID: 4588016
    [No Abstract]   [Full Text] [Related]  

  • 18. [The efficacy of treatment of diffuse infiltrative-pneumonic pulmonary tuberculosis].
    Pervova TN; Polevikt GK
    Probl Tuberk; 1966; 44(4):10-5. PubMed ID: 6011830
    [No Abstract]   [Full Text] [Related]  

  • 19. [The four-fold treatment of serious forms of pulmonary tuberculosis].
    Amsler R
    Sem Ther; 1966; 42(6):365-6. PubMed ID: 5984624
    [No Abstract]   [Full Text] [Related]  

  • 20. [Controlled therapeutic study of 5 intermittent chemotherapy regimens for pulmonary tuberculosis. 4th international study of the UICT].
    Bignall JR
    Bull Int Union Tuberc; 1974; 49(1):422-6. PubMed ID: 4143179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.